Prognostic value of quality‐of‐life scores in patients with breast cancer undergoing preoperative chemotherapy

BACKGROUND: Recently, evaluation of quality of life (QOL) has been recognized as a significant outcome measure in the treatment of several cancers. In this study, the Anti‐Cancer Drugs–Breast (ACD‐B) QOL score was used to assess disease‐specific survival in women with breast cancer undergoing preope...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, K., Kashiwagi, S., Fukui, Y., Goto, W., Asano, Y., Morisaki, T., Takashima, T., Hirakawa, K., Ohira, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354182/
https://www.ncbi.nlm.nih.gov/pubmed/30734014
http://dx.doi.org/10.1002/bjs5.50108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354182/
https://www.ncbi.nlm.nih.gov/pubmed/30734014
http://dx.doi.org/10.1002/bjs5.50108

Ejemplares similares